Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia

Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia

Abstract Case Approximately 3%‐25% of cases of endometrial carcinoma (EC) or atypical endometrial hyperplasia (AH) occur in women aged <40 years and conservative treatment with high‐dose medroxyprogesterone acetate (MPA) is administered to women who wish to preserve their fertility. Here is repor...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Toshiya Matsuzaki, Takeshi Iwasa, Takako Kawakita, Yuri Yamamoto, Akiko Abe, Aki Hayashi, Kiyohito Yano, Masato Nishimura, Akira Kuwahara, Minoru Irahara
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	Wiley 2018-07-01
Σειρά:	Reproductive Medicine and Biology
Θέματα:	assisted reproductive technology atypical endometrial hyperplasia conservative treatment endometrial carcinoma medroxyprogesterone acetate
Διαθέσιμο Online:	https://doi.org/10.1002/rmb2.12209

Παρόμοια τεκμήρια

Medroxyprogesterone Acetate Plus Metformin to Prevent Persistent Endometrial Hyperplasia
ανά: Vakkas Korkmaz, κ.ά.
Έκδοση: (2013-08-01)

Results of surgical treatment of atypical endometrial hyperplasia
ανά: O. A. Gornykh, κ.ά.
Έκδοση: (2014-07-01)

Modern approaches to the diagnosis of endometrial hyperplasia
ανά: M. M. Damirov, κ.ά.
Έκδοση: (2025-02-01)

Microsatellite instability as a reliable marker of coexisting endometrial cancer in atypical endometrial hyperplasia
ανά: А. E. Protasova, κ.ά.
Έκδοση: (2024-07-01)

Endometrial Atypical Hyperplasia and Risk of Endometrial Cancer
ανά: An-Ju Chou, κ.ά.
Έκδοση: (2024-11-01)

Endometrial hyperplasia and progesterone resistance: a complex relationship
ανά: Mekan R. Orazov, κ.ά.
Έκδοση: (2023-03-01)

The reproductive function of patients with prior atypical endometrial hyperplasia and endometrial cancer treatment: cohort study
ανά: Lana G. Dzhanashvili, κ.ά.
Έκδοση: (2022-09-01)

Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia
ανά: Fariba Behnamfar, κ.ά.
Έκδοση: (2014-01-01)

Reproductive advance of fertility preservation in patients with early endometrial carcinoma or endometrial atypical hyperplasia
ανά: Jiao Yu, κ.ά.
Έκδοση: (2022-12-01)

Laparoscopic surgery for atypical endometrial hyperplasia with awareness regarding the possibility of endometrial cancer
ανά: Misato Kamii, κ.ά.
Έκδοση: (2023-01-01)

Features of the course of pregnancy and childbirth after conservative treatment of initial atypical hyperplasia and endometrial cancer
ανά: A. V. Charkhifalakyan, κ.ά.
Έκδοση: (2025-01-01)

Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women
ανά: Stefano Uccella, κ.ά.
Έκδοση: (2022-09-01)

The retrospective analysis results of the endometrial tissue pathological conditions development
ανά: V. V. Artyomenko, κ.ά.
Έκδοση: (2020-11-01)

Recurrent endometrial atypical hyperplasia diagnosed by pathological examination of the placenta from a live birth: a case report
ανά: Weilu Wu, κ.ά.
Έκδοση: (2023-09-01)

Prevalence of Co-existing Endometrial Carcinoma in Patients with Preoperative Diagnosis of Endometrial Hyperplasia
ανά: Pinar Kadirogullari, κ.ά.
Έκδοση: (2015-10-01)

Diagnostic Value of ADC in Distinguishing Endometrial Cancer from Atypical Endometrial Hyperplasia and Within Molecular Subtypes
ανά: Xu S, κ.ά.
Έκδοση: (2025-02-01)

Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy
ανά: Junyu Chen, κ.ά.
Έκδοση: (2021-09-01)

Liquid-based endometrial cytology associated with curettage in the investigation of endometrial carcinoma in postmenopausal women
ανά: Ke Ma, κ.ά.
Έκδοση: (2016-12-01)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
ανά: Jun Guan, κ.ά.
Έκδοση: (2022-10-01)

Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
ανά: Junyu Chen, κ.ά.
Έκδοση: (2022-02-01)

Clinical features and outcome of 15 patients with recurrent endometrial cancer or atypical endometrial hyperplasia received primary fertility-sparing therapy followed by hysterectomy
ανά: Yuanting Li, κ.ά.
Έκδοση: (2021-03-01)

The proliferation markers in patients with different forms of hyperplastic endometrial processes
ανά: Yuri Krut, κ.ά.
Έκδοση: (2022-05-01)

Correlation of plasma adipokines with endometrial atypical hyperplasia and type I/II endometrial cancer
ανά: Xinxin Zhu, κ.ά.
Έκδοση: (2023-12-01)

Impacts of ovarian reserve on conservative treatment for endometrial cancer and atypical hyperplasia
ανά: Pengfei Wu, κ.ά.
Έκδοση: (2024-01-01)

ENDOMETRIAL PRECANCER: DEFINITION OF CONCEPTS, TACTICS
ανά: Iu. Iu. Tabakman, κ.ά.
Έκδοση: (2016-09-01)

Atypical Endometrial Hyperplasia and Unexpected Cancers at Final Histology: A Study on Endometrial Sampling Methods and Risk Factors
ανά: Luca Giannella, κ.ά.
Έκδοση: (2020-07-01)

Fertility-sparing re-treatment for endometrial cancer and atypical endometrial hyperplasia patients with progestin-resistance: a retrospective analysis of 61 cases
ανά: Junyu Chen, κ.ά.
Έκδοση: (2024-06-01)

Analysis of Factors Associated With Recurrence of Early-Stage Endometrial Carcinoma and Atypical Endometrial Hyperplasia in Infertile Women After In Vitro Fertilization Treatment
ανά: Yaxing Guo, κ.ά.
Έκδοση: (2022-06-01)

Menopausal Status Combined with Serum CA125 Level Significantly Predicted Concurrent Endometrial Cancer in Women Diagnosed with Atypical Endometrial Hyperplasia before Surgery <sup>†</sup>
ανά: Yaochen Lou, κ.ά.
Έκδοση: (2021-12-01)

Clinical, Sonographic, and Hysteroscopic Features of Endometrial Carcinoma Diagnosed after Hysterectomy in Patients with a Preoperative Diagnosis of Atypical Hyperplasia: A Single-Center Retrospective Study
ανά: Luca Pace, κ.ά.
Έκδοση: (2022-12-01)

New classification system of endometrial hyperplasia WHO 2014 and its clinical implications
ανά: Katarzyna Sobczuk, κ.ά.
Έκδοση: (2017-10-01)

Concurrent endometrial intraepithelial carcinoma (EIC) and endometrial hyperplasia
ανά: Steven Wang, MD, κ.ά.
Έκδοση: (2015-03-01)

Age-related relationship between the development of hyperplastic processes and VEGF expression in endometrial cells
ανά: Z. V. Chumak, κ.ά.
Έκδοση: (2020-04-01)

The incidence rates of endometrial hyperplasia and endometrial cancer: a four-year population-based study
ανά: Jin-Sung Yuk
Έκδοση: (2016-08-01)

Non-atypical endometrial hyperplasia: risk factors for occult endometrial atypia and malignancy in patients managed with hysterectomy
ανά: Lee Shi Hui, κ.ά.
Έκδοση: (2021-05-01)

Effects of isoflavone supplementation on endometrial thickness, endometrial hyperplasia, and cancer in ovariectomized cats
ανά: Mona Negadmonfared, κ.ά.
Έκδοση: (2022-01-01)

Atypical Endometrial Hyperplasia Arising in a Cesarean Section Scar: A Mechanism of Malignant Transformation
ανά: Marta Monist, κ.ά.
Έκδοση: (2019-04-01)

Comparative effects of progestin-based combination therapy for endometrial cancer or atypical endometrial hyperplasia: a systematic review and network meta-analysis
ανά: Jie Cui, κ.ά.
Έκδοση: (2024-05-01)

Hyperplasia and endometrial precancer
ανά: O. A. Gornikh, κ.ά.
Έκδοση: (2014-08-01)

Current research of Assisted Reproductive Technology for women with early endometrial cancer and atypical endometrial hyperplasia after conservative treatment
ανά: Yan-le Jiang, κ.ά.
Έκδοση: (2024-06-01)